{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T17:48:08Z","timestamp":1759600088420},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.jocn.2014.09.024","type":"journal-article","created":{"date-parts":[[2015,2,9]],"date-time":"2015-02-09T14:35:25Z","timestamp":1423492525000},"page":"670-675","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Diagnostic value of aquaporin 4 antibody in assessing idiopathic inflammatory demyelinating central nervous system diseases in Egyptian patients"],"prefix":"10.1016","volume":"22","author":[{"given":"Nirmeen A.","family":"Kishk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noha T.","family":"Abokrysha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laila","family":"Rashed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagwa","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2014.09.024_b0005","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/brain\/awm047","article-title":"Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis","volume":"130","author":"Misu","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2014.09.024_b0010","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/72256","article-title":"Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke","volume":"6","author":"Manley","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.jocn.2014.09.024_b0015","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/ana.22023","article-title":"Protective role of aquaporin-4 water channels after contusion spinal cord injury","volume":"67","author":"Kimura","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2014.09.024_b0180","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","article-title":"The clinical course of neuromyelitis optica (Devic\u2019s syndrome)","volume":"53","author":"Wingerchuk","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2014.09.024_b0025","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2014.09.024_b0030","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.jocn.2014.09.024_b0035","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2014.09.024_b0040","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jocn.2014.09.024_b0045","first-page":"145","article-title":"Multiple sclerosis in South East Asia and diagnostic criteria for Asians","volume":"13","author":"Chong","year":"2008","journal-title":"Neurol Asia"},{"key":"10.1016\/j.jocn.2014.09.024_b0050","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1212\/WNL.38.2.180","article-title":"MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT","volume":"38","author":"Paty","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2014.09.024_b0055","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1093\/brain\/120.11.2059","article-title":"Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis","volume":"120","author":"Barkhof","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2014.09.024_b0060","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1590\/S0004-282X2012001000010","article-title":"The expanded spectrum of neuromyelitis optica: evidences for a new definition","volume":"70","author":"Lana-Peixoto","year":"2012","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.jocn.2014.09.024_b0065","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010; revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2014.09.024_b0070","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in MS: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2014.09.024_b0185","article-title":"Detection of anti-aquaporin antibodies in human serum and CSF by ELISA based assay","volume":"57","author":"Tokoro","year":"2011","journal-title":"Clin Chem"},{"key":"10.1016\/j.jocn.2014.09.024_b0080","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/1352458508098372","article-title":"Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30years","volume":"15","author":"Osoegawa","year":"2009","journal-title":"Mult Scler"},{"key":"10.1016\/j.jocn.2014.09.024_b0190","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1212\/WNL.0b013e31822c61b1","article-title":"AQP4 antibody-positive Thai cases. Clinical features and diagnostic problems","volume":"77","author":"Siritho","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2014.09.024_b0090","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1177\/1352458510376640","article-title":"Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity","volume":"16","author":"Kim","year":"2010","journal-title":"Mult Scler"},{"key":"10.1016\/j.jocn.2014.09.024_b0095","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1007\/s00415-009-5171-x","article-title":"Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution","volume":"256","author":"Bizzoco","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.jocn.2014.09.024_b0100","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1212\/01.WNL.0000145762.60562.5D","article-title":"Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis","volume":"63","author":"Cree","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2014.09.024_b0195","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1136\/jnnp.73.4.429","article-title":"Optic neuromyelitis syndrome in Brazilian patients","volume":"73","author":"Papais-Alvarenga","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2014.09.024_b0110","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1212\/WNL.0b013e3181e2414b","article-title":"Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study","volume":"75","author":"Takano","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2014.09.024_b0115","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1007\/s00330-009-1425-3","article-title":"Spinal cord lesions in patients with neuromyelitis optica: a retrospective long-term MRI follow-up study","volume":"19","author":"Krampla","year":"2009","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jocn.2014.09.024_b0120","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1468-1331.2008.02088.x","article-title":"Acute partial transverse myelitis: risk factors for conversion to multiple sclerosis","volume":"15","author":"Sellner","year":"2008","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jocn.2014.09.024_b0125","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/sc.2008.143","article-title":"Diagnostic workup of patients with acute transverse myelitis: spectrum of clinical presentation, neuroimaging and laboratory findings","volume":"47","author":"Sellner","year":"2009","journal-title":"Spinal Cord"},{"key":"10.1016\/j.jocn.2014.09.024_b0200","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/1352458507082617","article-title":"Brain magnetic resonance imaging findings in acute relapses of neuromyelitis optica spectrum disorders","volume":"14","author":"Cabrera-G\u00f3mez","year":"2008","journal-title":"Mult Scler"},{"key":"10.1016\/j.jocn.2014.09.024_b0135","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1600-0404.2008.01012.x","article-title":"Brain magnetic resonance imaging abnormalities in neuromyelitis optica","volume":"118","author":"Li","year":"2008","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jocn.2014.09.024_b0140","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1523\/JNEUROSCI.17-01-00171.1997","article-title":"Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain","volume":"17","author":"Nielsen","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.jocn.2014.09.024_b0205","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1007\/s00415-011-6384-3","article-title":"When is neuromyelitis optica diagnosed after disease onset?","volume":"259","author":"Uzawa","year":"2012","journal-title":"J Neurol"},{"key":"10.1016\/j.jocn.2014.09.024_b0210","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1177\/1352458512472748","article-title":"Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders","volume":"19","author":"Kim","year":"2013","journal-title":"Mult Scler"},{"key":"10.1016\/j.jocn.2014.09.024_b0155","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1515\/CCLM.2010.127","article-title":"Immunoglobulin M antibodies to aquaporin-4 in neuromyelitis optica and related disorders","volume":"48","author":"Jarius","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jocn.2014.09.024_b0160","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1212\/WNL.0b013e31826aac4e","article-title":"Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype","volume":"79","author":"Kitley","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2014.09.024_b0165","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1093\/brain\/awn240","article-title":"Antibody to aquaporin-4 in the long-term course of neuromyelitis optica","volume":"131","author":"Jarius","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2014.09.024_b0170","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1468-1331.2009.02928.x","article-title":"Relapsing neuromyelitis optica: demographic and clinical features in Iranian patients","volume":"17","author":"Sahraian","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jocn.2014.09.024_b0215","first-page":"S53","article-title":"Benign course in neuromyelitis optica","volume":"17","author":"Par","year":"2011","journal-title":"Mult Scler"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586814006390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586814006390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T03:48:43Z","timestamp":1717732123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586814006390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0967586814006390"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2014.09.024","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic value of aquaporin 4 antibody in assessing idiopathic inflammatory demyelinating central nervous system diseases in Egyptian patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2014.09.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}